Suggestions
Osama Hashmi MD MPH
Dermatologist | Cofounder - Impiricus
Osama Hashmi is a professional with a diverse background in healthcare and policy. He is the Founder of Vitamin C LLC and has held various roles in reputable organizations.
Osama has an extensive educational background, including studying Chief Resident in Dermatology at Emory University School of Medicine, Doctor of Medicine (M.D.) at Medical College of Georgia at Augusta University, Bachelor of Science (B.S.) in Biology from The University of Georgia, and a Master of Public Health (M.P.H.) in Health Policy and Management from The University of Georgia. He also studied at Lakeside.
Throughout his career, Osama has been involved with organizations such as Impiricus, Emory Healthcare, Stanford University, Greater New York Hospital Association, Behan Law, University of Georgia, Athens Health Network, and Roosevelt Institute@UGA in various capacities.
With experience as the Head of Product, Resident Physician, CEO, and Research Assistant, among other roles, Osama has showcased his versatility and expertise in the healthcare and policy sector.
By combining his medical knowledge with a deep understanding of health policy, Osama Hashmi continues to make significant contributions to the field.
Highlights
Surveys show 55% of doctors feel overwhelmed by content shared by pharma companies.
Physicians overwhelmingly want data on drug safety, effectiveness and clinical trials. They simply have no time or interest in overtly promotional ads.
In my practice, I’m back to back with patients. The few minutes I have to sit down, its often to complete a note or followup on my patients.
Doctors don’t want sales reps showing up when they have a line of 10 patients out the door. We want short-form bursts of information and links to studies we can dive into at our leisure.
Doctors don’t want advertisements that proclaim every new pharma product to be a wonder drug. We want peer-reviewed data that clearly shows who can be helped.
Doctors don’t want generic messaging that could apply to any health care professional. We want materials that make sense to our specialty and our practice.
It’s no wonder why: Time is our most valuable asset. An alarming 63% of physicians show signs of burnout, a figure that has nearly doubled since the pre-pandemic days. It’s typical to see 20 patients in a day in a slow moving practice.
Yet the stakes for health care companies to reach doctors are incredibly high. The average doctor controls about $2 million a year in health care spending through their patients. Overall, doctors control about 80% of the nation’s $4.3 trillion in annual health care spending.
It’s no wonder pharma companies spend $30 billion a year marketing to doctors.
The single biggest thing pharma companies can do to be successful with doctors is to get to the point and be as efficient as possible in a way that impacts patients.
The data shows companies have gotten better at this after the pandemic by offering more digital outreach, but there’s such a thing as too much. We don’t have time for spam.
Before the pandemic, 72% of doctors got in-person meetings with pharma reps; now, it’s 54%. Those touch-points have been replaced with more webinars, emails and text messages.
As more data becomes available, pharma companies have been able to fine-tune custom messaging based on each health care professional’s preference. The firms that are able to leverage that data to break through the noise and reach doctors in a way that is helpful and convenient to them will be the ones that win.
Of all the problems facing the U.S. healthcare system, one factor you’re probably not considering is the stress doctors face over massive student debt.
Yes, physicians make a ton of money. But the average doctor leaves school with a staggering $250,000 in total debt, up from $90,000 in 2000. With interest rates that typically top 7%, monthly debt bills amount to a mortgage payment.
Add in 24-hour shifts and years of stressful residency and you get a nightmare for doctors’ mental health. That can’t be good for patients.
A massive study of internal medicine residents (link in comments) found 62% of those with large student debt had at least one symptom of burnout, compared to 44% of those with less debt.
Their quality of care was also hurt. The research showed the gap in exam scores between high-debt and low-debt residents was the same as the gap between second-year students and first-years.
The issue is significant enough that more large employers are luring doctors with the promise of helping with their student debt. About 18% of hospitals offer to pay down incoming doctors’ student debt, paying an average of $100,000 in exchange for working there for at least three years.
This is not to say that people should feel bad for doctors. The same reality of surging student debt is facing graduates of all types - except without the promise of the median $229,000 salary for physicians.
But considering how much we value having as many great committed doctors as possible, it’s less than ideal.
Obviously one idea is to wipe out student debt, but whatever you think of that, it seems highly unlikely after being struck down by the Supreme Court, and in any event, high-earners like doctors would not have been eligible under President Joe Biden’s plan.
More realistically, smaller, less-known programs are already helping. Some doctors have reported tens or even hundreds of thousands of student loans being forgiven under things like the Public Service Loan Forgiveness program. That plan allows health care professionals and others who work at non-profits or public institutions to wipe out their remaining debts after 10 years of payments.
My biggest fear is that people from poorer families look at the financial reality of going to medical school and say “no” and we end up with fewer great doctors than we need.
And medical school tuition keeps going higher while alternative, less regulated pathways become cheaper.
Experts project our physician shortage will grow to 86,000 in the next decade, and that’s not good for anyone - especially patients.
